K. Jellinger et al., CHEMICAL EVIDENCE FOR 6-HYDROXYDOPAMINE TO BE AN ENDOGENOUS TOXIC FACTOR IN THE PATHOGENESIS OF PARKINSONS-DISEASE, Journal of neural transmission. Supplementum, (46), 1995, pp. 297-314
The presence of 5-Hydroxydopamine (5-OHDA) and 6-Hydroxydopamine (6-OH
DA) in the urine of parkinsonian patients on levodopa medication was r
eported by Andrew et al. (1993). To answer the question about the puta
tive relevance of 6-OHDA endogenously formed in the brain for the path
ogenesis of Parkinson's disease (PD), the chemical mechanisms leading
to dopamine-coordinative complexes were investigated in vitro. Kinetic
studies of the reaction of dopamine (DA) with dioxygen over the pH ra
nge 7.0-9.0, where it reacts spontaneously without the necessity of me
tal-ion analysis, show that stoichiometric amounts of H2O2 are produce
d. Pink dopaminochrome, another oxidation product, is not stable and f
urther reacts - without the consumption of dioxygen - to form the inso
luble polymeric material known as melanin. Based on these results, the
in vitro chemistry of the reactions of DA, 5-OHDA, and 6-OHDA in the
presence of Fe3+ and dioxygen are studied. A mechanism for the initiat
ion of a chain reaction is suggested by which excess Fe3+ could arise,
and its relevance for the degeneration of dopaminergic neurons in PD
is discussed. Detailed studies on the release of ferritin bound iron (
0.2-1.4 mu M Fe3+) by synthetic DA (200 mu M) may provide further insi
ght into the pathogenesis of PD,but further studies are warranted to e
lucidate the molecular basis of this neurodegenerative disorder of the
extrapyramidal system.